Recent News
Giant Steps Back in the Fight to Ban Asbestos In the United States
Under the Obama Administration, The Toxic Substances Control Act (TSCA) was updated to give the Environmental Protection Agency (EPA) more authority to ban asbestos completely in the United States. The[…]
Read MoreDecrease in Survival Rate Among Those Who Receive Non-traditional Cancer Treatment
Complementary medicine and alternative medicine may sound one in the same, but are vastly different in how each is used, and varying results often make people wary of its true[…]
Read MoreNew Surgical Technique Illuminates Previously Undetected Mesothelioma Tumors
In addition to chemotherapy, radiation therapy, and immunotherapy, those suffering from mesothelioma also have the option for surgery (if they are physically able). Surgery is one of the better options[…]
Read MoreMetal-based Compound May Reduce Tumor Size in Pleural, Peritoneal Mesothelioma
Mesothelial cells are found in the lining of major organs such as the chest or the abdomen. When asbestos fibers are inhaled or ingested, they slice through the soft tissue[…]
Read MorePotential Breakthrough in Immunotherapy after Nivolumab Study Results
Immunotherapy treatments have once again made headlines, revolutionizing modern medicine and the way we have come to understand cancer treatment. The latest study results published in the American Journal of[…]
Read MorePneumothorax Helps Improve CT Scans, Early Detection for Mesothelioma Patients
Diagnosing mesothelioma in the early stages of the disease has proven to be a difficult task, and to better improve chances of survival from this aggressive cancer, the cancer needs[…]
Read MoreWhy is Chemotherapy Often Ineffective in Those Suffering from Mesothelioma?
Mesothelioma is a difficult cancer to treat for a multitude of reasons. A mesothelioma diagnosis is rare – only about 3,000 people per year in the United States are diagnosed[…]
Read MoreNintedanib May Surpass Bevacizumab as a More Effective Chemotherapy Treatment for Mesothelioma
In 2016, scientists and researchers were excited to begin Phase II of the clinical trial involving treating patients with malignant pleural mesothelioma with Nintedanib, a triple angiokinase inhibitor designed to[…]
Read MoreEPA Proposes New Rules For Asbestos; Anti-Asbestos Advocates Concerned
In June 2016, former President Obama signed the Frank R. Lautenberg Chemical Safety for the 21st Century Act as an amendment to the Toxic Substances Control Act (TSCA), and since[…]
Read MoreUpdated Modified RECIST to Better Evaluate Treatment Response in Mesothelioma
The Response Evaluation Criteria in Solid Tumors (RECIST) was established nearly two decades ago by the European Organization for Research and Treatment of Cancer and the National Cancer Institute of[…]
Read More